Gertler James Steven 4

4 · RRE Ventures Acquisition Corp. · Filed May 5, 2026

AI-generated summary of this filing

Updated May 5, 2026

RRE Ventures (RREV) Director James Gertler Receives Grants

What Happened

James Steven Gertler, a director of RRE Ventures Acquisition Corp. (RREV), received three derivative grants/awards. He was credited with 30,000 and 37,500 derivative shares at $0.00 (grants) on 2026-03-02 and 2026-03-24, and acquired 125,000 derivative securities on 2026-05-01 at $1.00 each for a total cash outlay of $125,000. These transactions are acquisitions (A) — i.e., awards/grants or other acquisitions of derivative securities — rather than open-market purchases or sales.

Key Details

Transaction dates and prices:
- 2026-03-02: 30,000 shares at $0.00 (grant)
- 2026-03-24: 37,500 shares at $0.00 (grant)
- 2026-05-01: 125,000 shares at $1.00 each (total $125,000)
Total new derivative securities received: 192,500.
Shares owned after transaction: Not specified in the provided filing excerpt.
Filing timeliness: Form filed 2026-05-05. The March 2 and March 24 grants were reported late (required to be on a Form 4 within two business days of the transaction). The May 1 acquisition was filed on 2026-05-05, which is within two business days given the weekend.
Footnotes from the filing:
- F1: Class B ordinary shares convert one-for-one into Class A ordinary shares at the issuer’s initial business combination (no expiration).
- F2: Some securities were previously reported on a Form 3 by the reporting person.
- F3: Private placement warrants (if applicable) become exercisable 30 days after the issuer’s initial business combination and expire five years after that combination (or earlier upon liquidation).

Context

These were derivative grants/awards (not open-market buys or sales). For retail investors, awards at $0 often reflect founder-class or compensation-related shares that convert into publicly tradable Class A shares upon a business combination; the $1.00 acquisition suggests a paid private-placement-type security. Derivative instruments (like Class B shares or private placement warrants) have conversion/exercise rules (see footnotes) and may not be immediately tradable. As always, insider grants are factual signals of position but do not by themselves explain motivation.

Form 4

Period: 2026-03-02

Director

Transactions

Award
Class B Ordinary Shares
[F1][F2]
2026-03-02+30,000→ 30,000 total
→ Class A Ordinary Shares (30,000 underlying)
Award
Class B Ordinary Shares
[F1][F2]
2026-03-24+37,500→ 67,500 total
→ Class A Ordinary Shares (37,500 underlying)
Award
Warrant
[F3]
2026-05-01$1.00/sh+125,000$125,000→ 125,000 total
Exercise: $11.50→ Class A Ordinary Shares (125,000 underlying)

Footnotes (3)

[F1]The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date.
[F2]These securities were previously reported on a Form 3 filed by the Reporting Person.
[F3]The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.

Signature

/s/ Philip Kassin, Attorney-in-Fact|2026-05-05

1 file